Sandoz accelerates generic tirzepatide and semaglutide approvals

TradingView News recap says the FDA accepted Sandoz’s filing for generic tirzepatide, and it won Canadian and Brazilian approvals for semaglutide (including Owozy in Brazil), plus a collaboration to expand biosimilar and rare-disease reach.